{
  "docId": "019de073-dba4-758b-bcbe-08ad83e87d71",
  "docSlug": "afc13b14322819221680611098a4aee7",
  "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides",
  "authorId": "third-harmonic-bio",
  "authorName": "Third Harmonic Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 20,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "product_demo",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a combination of a bulleted list for qualitative benefits and a table for quantitative selectivity data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/8",
  "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71",
  "deckJsonHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71.json",
  "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.03,
        "y": 0.225
      },
      "kind": "image",
      "text": "Emerging Product Profile",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90b35660-1b2f-484b-a21a-6364a5c5943b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.23,
        "y": 0.23
      },
      "kind": "list",
      "text": "Potent KIT inhibitor; High kinome selectivity; Depleted mast cells in relevant GI, skin and lung tissues of rats and dogs; Demonstrated efficacy in rat models of dermal anaphylaxis and asthma; Favorable pharmacokinetic profile; No evidence of off-target liabilities",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0768dc3d-f585-4a88-ab0b-a6bff6297b7b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.75,
        "x": 0.12,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "KIT, CSF1R, PDGFR-α most potently inhibited in 231 and 40 kinase panels in biochemical assays and cell based assays, respectively. GI=gastrointestinal; CSF1R=colony stimulating factor 1 receptor; FMS=Feline McDonough sarcoma tyrosine kinase receptor...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e3a2836-0827-47c1-88c5-a57519b15536",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.32,
        "x": 0.64,
        "y": 0.27
      },
      "kind": "table",
      "text": "Inhibition of Kinases by THB001 in Ba/F3 Assays",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdbfe18e-c77d-4e55-bb1a-0e3acaf41024",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "THB001: Highly Selective Oral Wild-Type KIT Inhibitor",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16cb3e3f-7cb8-4619-9019-e40330583805",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 8,
      "beatId": "113f84d9-dc3a-4ff6-b7be-c644841504ba",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Slide 8 provides an overview of THB001, the highly selective oral wild-type KIT inhibitor",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    },
    {
      "to": 14,
      "from": 7,
      "beatId": "45cf8a86-de32-4d74-8704-aa8f3cd45c24",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 7-14 provide data and results on THB001, including its ability to inhibit mast cell activity",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}